Obesity rates have dropped alongside surging use of Ozempic, Wegovy and other blockbuster GLP-1 weight-loss drugs, a new report shows.

The obesity rate for adults in the United States slid from a record high of nearly 40% in 2022 to 37% in 2025, according to Gallup Poll results published Tuesday. That is a nearly 8 million decline in the number of obese adults nationwide. MORE: How to make healthier choices when eating fast food

The survey also found that the percentage of people in the United States using GLP-1 drugs for weight loss has spiked over the past year, from 5.8% in February 2024 to 12.4% now.

But the increase in the use of GLP-1s and falling obesity rates have not led to a decrease in diabetes.The diabetes rate reached an all-time high of 13.8% in 2025, up from 13.4% i

See Full Page